MX384921B - Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. - Google Patents
Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca.Info
- Publication number
- MX384921B MX384921B MX2017004516A MX2017004516A MX384921B MX 384921 B MX384921 B MX 384921B MX 2017004516 A MX2017004516 A MX 2017004516A MX 2017004516 A MX2017004516 A MX 2017004516A MX 384921 B MX384921 B MX 384921B
- Authority
- MX
- Mexico
- Prior art keywords
- disease
- methods
- systems
- celiac disease
- inflammatory bowel
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/205—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Campylobacter (G)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/06—Gastro-intestinal diseases
- G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Rehabilitation Therapy (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462061877P | 2014-10-09 | 2014-10-09 | |
| US201462085825P | 2014-12-01 | 2014-12-01 | |
| PCT/US2015/054655 WO2016057772A1 (en) | 2014-10-09 | 2015-10-08 | Methods and systems for distinguishing irritable bowel syndrome from inflammatory bowel disease and celiac disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2017004516A MX2017004516A (es) | 2017-10-12 |
| MX384921B true MX384921B (es) | 2025-03-14 |
Family
ID=55653760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2017004516A MX384921B (es) | 2014-10-09 | 2015-10-08 | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US10132814B2 (enExample) |
| EP (1) | EP3204771B1 (enExample) |
| JP (1) | JP6784669B2 (enExample) |
| KR (1) | KR102426541B1 (enExample) |
| CN (1) | CN107003308B (enExample) |
| AU (1) | AU2015330872B2 (enExample) |
| CA (1) | CA2962493C (enExample) |
| ES (1) | ES3028294T3 (enExample) |
| IL (1) | IL251606B (enExample) |
| MX (1) | MX384921B (enExample) |
| NZ (1) | NZ730490A (enExample) |
| PL (1) | PL3204771T3 (enExample) |
| PT (1) | PT3204771T (enExample) |
| RU (1) | RU2706361C2 (enExample) |
| SG (1) | SG11201702395WA (enExample) |
| WO (1) | WO2016057772A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2010213708B2 (en) | 2009-02-11 | 2015-12-10 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
| US11693009B2 (en) | 2009-02-11 | 2023-07-04 | Cedars-Sinai Medical Center | Methods for detecting post-infectious irritable bowel syndrome |
| MX383428B (es) | 2012-09-17 | 2025-03-13 | Cedars Sinai Medical Center | Determinaciòn de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia. |
| KR102259588B1 (ko) | 2013-10-09 | 2021-06-02 | 세다르스-신나이 메디칼 센터 | 과민성 장 증후군 및 염증성 장 질환의 진단 및 치료 |
| MX384921B (es) | 2014-10-09 | 2025-03-14 | Cedars Sinai Medical Center | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. |
| EP3573650A4 (en) | 2017-01-30 | 2020-12-09 | Cedars-Sinai Medical Center | DIAGNOSIS OF SCLERODERMIA |
| EP3913371A1 (en) | 2020-05-18 | 2021-11-24 | Neuroimmun GmbH | Method and kit for diagnosting irritable bowel syndrome and for its relief through dietary interventions |
| CN113447649B (zh) * | 2021-07-01 | 2022-04-19 | 浙江大学 | 一种检测抗粘着斑蛋白-IgG抗体的试剂盒 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4946778A (en) | 1987-09-21 | 1990-08-07 | Genex Corporation | Single polypeptide chain binding molecules |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5691151A (en) | 1994-10-07 | 1997-11-25 | Regents Of University Of California | Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca |
| US6562629B1 (en) | 1999-08-11 | 2003-05-13 | Cedars-Sinai Medical Center | Method of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth by detecting the presence of anti-saccharomyces cerivisiae antibodies (asca) in human serum |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| FR2806805A1 (fr) | 2000-03-22 | 2001-09-28 | Centre Nat Rech Scient | SEQUENCE PEPTIDIQUES COMPRENANT UN OU PLUSIEURS MOTIFS DE LIAISON AUX PROTEINES DE LA FAMILLE Ena/VASP, ET LEURS UTILISATIONS |
| US20040018528A1 (en) | 2002-05-17 | 2004-01-29 | Sugen, Inc. | Novel biomarkers of tyrosine kinase inhibitor exposure and activity in mammals |
| AU2003291625B2 (en) | 2002-09-16 | 2009-10-08 | Genentech, Inc. | Compositions and methods for the treatment of immune related diseases |
| US7595386B2 (en) | 2003-01-24 | 2009-09-29 | William Beaumont Hospital | Methods and compositions for heat activated gene therapy using cytolethal distending toxin |
| EP1617846A1 (en) * | 2003-04-08 | 2006-01-25 | Progenics Pharmaceuticals, Inc. | The use of peripheral opiois antagonists, especially methylnaltrexone to treat irritable bowel syndrome |
| EP2280285A1 (en) | 2003-09-15 | 2011-02-02 | Oklahoma Medical Research Foundation | Method of using cytokine assays to diagnose, treat, and evaluate inflammatory and autoimmune diseases |
| ES2456710T3 (es) | 2003-12-05 | 2014-04-23 | Fuso Pharmaceutical Industries Ltd. | Genes de toxinas de distensión citoletales como dianas para la detección de bacterias Campylobacter |
| US20080085524A1 (en) * | 2006-08-15 | 2008-04-10 | Prometheus Laboratories Inc. | Methods for diagnosing irritable bowel syndrome |
| EP2102367A2 (en) | 2006-11-09 | 2009-09-23 | XDX, Inc. | Methods for diagnosing and monitoring the status of systemic lupus erythematosus |
| JP2011507509A (ja) * | 2007-12-20 | 2011-03-10 | インデックス・ダイアグノスティックス・エイビイ | Ｉｂｄとｉｂｓとの区別、ｉｂｄの疾患タイプ間の更なる識別における使用する方法およびキット |
| WO2010045180A1 (en) * | 2008-10-13 | 2010-04-22 | Metabolon, Inc. | Biomarkers for inflammatory bowel disease and methods using the same |
| WO2010060098A1 (en) | 2008-11-24 | 2010-05-27 | Cedars-Sinai Medical Center | Antioxidant camptothecin derivatives and antioxidant antineoplastic nanospheres thereof |
| BRPI1008058A8 (pt) | 2009-02-11 | 2018-03-27 | Cedars Sinai Medical Center | uso de antibióticos para reduzir a probabilidade de desenvolver síndrome do intestino irritável pós-infecciosa |
| AU2010213708B2 (en) | 2009-02-11 | 2015-12-10 | Cedars-Sinai Medical Center | Antibody to cytolethal distending toxin of Campylobacter jejuni |
| FR2942541A1 (fr) | 2009-02-25 | 2010-08-27 | Assist Publ Hopitaux De Paris | Procede de diagnostic d'une vascularite |
| RU2397178C1 (ru) * | 2009-02-27 | 2010-08-20 | Федеральное государственное учреждение науки "Центральный научно-исследовательский институт эпидемиологии" Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека | Диагностическая тест-система в формате иммуночипа и способ серологической дифференциальной диагностики сифилиса |
| IT1400989B1 (it) | 2010-07-13 | 2013-07-05 | Segix Italia S R L Ora Istituto Biochimico Naz Savio S R L | Forme di somministrazione orale a rilascio controllato di rifampicina per il trattamento di infezioni batteriche dell' apparato intestinale. |
| GB201017520D0 (en) | 2010-10-15 | 2010-12-01 | Sense Proteomic Ltd | Biomarkers |
| JP5477671B2 (ja) | 2012-02-28 | 2014-04-23 | 三菱マテリアル株式会社 | サーミスタ用金属窒化物材料及びその製造方法並びにフィルム型サーミスタセンサ |
| MX383428B (es) * | 2012-09-17 | 2025-03-13 | Cedars Sinai Medical Center | Determinaciòn de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia. |
| KR102259588B1 (ko) | 2013-10-09 | 2021-06-02 | 세다르스-신나이 메디칼 센터 | 과민성 장 증후군 및 염증성 장 질환의 진단 및 치료 |
| MX384921B (es) | 2014-10-09 | 2025-03-14 | Cedars Sinai Medical Center | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. |
| EP3573650A4 (en) | 2017-01-30 | 2020-12-09 | Cedars-Sinai Medical Center | DIAGNOSIS OF SCLERODERMIA |
-
2015
- 2015-10-08 MX MX2017004516A patent/MX384921B/es unknown
- 2015-10-08 EP EP15849701.6A patent/EP3204771B1/en active Active
- 2015-10-08 KR KR1020177011301A patent/KR102426541B1/ko active Active
- 2015-10-08 ES ES15849701T patent/ES3028294T3/es active Active
- 2015-10-08 JP JP2017518834A patent/JP6784669B2/ja active Active
- 2015-10-08 CA CA2962493A patent/CA2962493C/en active Active
- 2015-10-08 CN CN201580067387.5A patent/CN107003308B/zh active Active
- 2015-10-08 WO PCT/US2015/054655 patent/WO2016057772A1/en not_active Ceased
- 2015-10-08 SG SG11201702395WA patent/SG11201702395WA/en unknown
- 2015-10-08 US US14/878,416 patent/US10132814B2/en active Active
- 2015-10-08 PT PT158497016T patent/PT3204771T/pt unknown
- 2015-10-08 PL PL15849701.6T patent/PL3204771T3/pl unknown
- 2015-10-08 AU AU2015330872A patent/AU2015330872B2/en active Active
- 2015-10-08 NZ NZ730490A patent/NZ730490A/en unknown
- 2015-10-08 RU RU2017115663A patent/RU2706361C2/ru active IP Right Revival
-
2017
- 2017-04-05 IL IL251606A patent/IL251606B/en active IP Right Grant
-
2018
- 2018-10-05 US US16/152,806 patent/US10690679B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017531801A (ja) | 2017-10-26 |
| KR102426541B1 (ko) | 2022-07-29 |
| CA2962493A1 (en) | 2016-04-14 |
| AU2015330872A1 (en) | 2017-04-13 |
| IL251606B (en) | 2020-08-31 |
| WO2016057772A1 (en) | 2016-04-14 |
| US20190187153A1 (en) | 2019-06-20 |
| NZ730490A (en) | 2021-07-30 |
| EP3204771A4 (en) | 2018-03-14 |
| CN107003308B (zh) | 2020-02-11 |
| KR20170067795A (ko) | 2017-06-16 |
| CN107003308A (zh) | 2017-08-01 |
| AU2015330872B2 (en) | 2021-04-22 |
| MX2017004516A (es) | 2017-10-12 |
| RU2706361C2 (ru) | 2019-11-18 |
| JP6784669B2 (ja) | 2020-11-11 |
| EP3204771B1 (en) | 2025-03-12 |
| SG11201702395WA (en) | 2017-04-27 |
| ES3028294T3 (en) | 2025-06-18 |
| CA2962493C (en) | 2023-01-10 |
| US10690679B2 (en) | 2020-06-23 |
| PT3204771T (pt) | 2025-05-20 |
| US20160103136A1 (en) | 2016-04-14 |
| EP3204771A1 (en) | 2017-08-16 |
| PL3204771T3 (pl) | 2025-07-28 |
| RU2017115663A3 (enExample) | 2019-05-16 |
| RU2017115663A (ru) | 2018-11-13 |
| IL251606A0 (en) | 2017-06-29 |
| US10132814B2 (en) | 2018-11-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX384921B (es) | Métodos y sistemas para distinguir el síndrome del intestino irritable de la enfermedad inflamatoria intestinal y la enfermedad celíaca. | |
| EA201791029A1 (ru) | Антитела против интерлейкина-33 и их применение | |
| MX388164B (es) | Anticuerpos y fragmentos anti-vista | |
| EA201692425A1 (ru) | Модифицированные биополимеры и способы их получения и использования | |
| EA201790984A1 (ru) | Анти-cd79b антитела и способы их применения | |
| CO2017003311A2 (es) | Sistema y método de reconocimiento de imágenes | |
| EP3923593C0 (en) | AREA RECONNAISSANCE | |
| CY1122233T1 (el) | Μεθοδος για την προβλεψη του αποτελεσμaτος μιας θεραπειας με αφλιβερσεπτη ενος ασθενους με υποψια οτι πασχει απο καρκινο | |
| EA201691610A8 (ru) | Анти-jagged1 антитела и способы применения | |
| IL281355B (en) | Compositions, methods and kits for diagnosis of a gastroenteropancreatic neuroendocrine neoplasm | |
| MX2017005888A (es) | Dispositivos, sistemas y metodos para la deteccion de analitos. | |
| MX2016004167A (es) | Diagnostico y tratamiento del sindrome del intestino irritable y la enfermedad inflamatoria intestinal. | |
| MX2016016458A (es) | Métodos para repetir tratamiento de síndrome del intestino irritable (ibs). | |
| MX383428B (es) | Determinaciòn de trastornos de la motilidad de los intestinos y la vejiga, y de la fibromialgia. | |
| EP3802885A4 (en) | DETECTION PROCEDURE | |
| EP3177298A4 (en) | Methods for treating inflammatory bowel disease using prostate specific membrane antigen (psma) inhibitors | |
| EA201692482A1 (ru) | Способы лечения заболеваний антителами, которые связывают рецептор колониестимулирующего фактора 1 (csf1r) | |
| BR112017007401A2 (pt) | métodos de detecção específicos | |
| EP3302666A4 (en) | GAS TREATMENT SYSTEM | |
| HUE043795T2 (hu) | Eljárás klasszikus sertéspestis vírusának specifikus detektálására | |
| EA201691203A1 (ru) | Твёрдые формы тенофовира | |
| EP3664786A4 (en) | METHOD OF TREATMENT OF SCHNITZLER'S SYNDROME | |
| EP3899531A4 (en) | PROCEDURE FOR DETECTING LUNG CANCER | |
| EP3682020C0 (en) | SEQUENCE DETECTION SYSTEM | |
| EA201790097A1 (ru) | Способы повторного лечения синдрома раздраженного кишечника (срк) |